Instrument Inactif

Communiqués Champignon Brands Deutsche Boerse AG

Actions

496 CA15850D1006

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	16/07	NE
Braxia Scientific Reports Q3 2024 Financial Results	29/02	NE
Braxia Scientific Reports Mandatory Conversion of Debentures	15/01	NE
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update	30/11	NE
Braxia Scientific : Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic	01/08/23	PU
Braxia Scientific : Reports Fiscal 2023 Financial Results	01/08/23	PU
Irwin Naturals Inc.: Update on LOI for Business Combination with Braxia Scientific Corp.	21/03/23	AQ
Update on LOI for Business Combination with Braxia Scientific Corp.	20/03/23	AQ
Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics	20/02/23	AQ
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals	07/02/23	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	30/01/23	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	27/01/23	AQ
Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US	10/01/23	AQ
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America	30/11/22	AQ
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers	04/10/22	AQ
Braxia Scientific Announces Board Appointment	22/09/22	AQ
Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022	09/09/22	AQ
Braxia Scientific Reports Q1 2023 Financial Results, Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients	30/08/22	AQ
Braxia Scientific Enters U.S. Telemedicine Industry, Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	04/08/22	AQ
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	03/08/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Champignon Brands Deutsche Boerse AG

Actions

496

CA15850D1006

Communiqués

Filtres